John Y. Caloz
2019
In 2019, John Y. Caloz earned a total compensation of $576.3K as Chief Financial Officer and Treasurer at CytRx, a 15% increase compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Option Awards | $76,300 |
| Salary | $400,000 |
| Total | $576,300 |
Caloz received $400K in salary, accounting for 69% of the total pay in 2019.
Caloz also received $100K in bonus and $76.3K in option awards.
Rankings
In 2019, John Y. Caloz's compensation ranked 11,330th out of 13,971 executives tracked by ExecPay. In other words, Caloz earned more than 18.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,330 out of 13,971 | 19th |
Division Manufacturing | 4,592 out of 5,701 | 20th |
Major group Chemicals And Allied Products | 1,807 out of 2,200 | 18th |
Industry group Drugs | 1,555 out of 1,886 | 18th |
Industry Biological Products, Except Diagnostic Substances | 341 out of 389 | 12th |
Source: SEC filing on June 12, 2020.
Caloz's colleagues
We found one more compensation record of an executive who worked with John Y. Caloz at CytRx in 2019.
2019
Steven Kriegsman
CytRx
Chief Executive Officer
News
CytRx CEO Stephen Snowdy's 2023 pay slips 3% to $545K
August 20, 2024
CytRx CEO Stephen Snowdy receives $563K in 2022
July 28, 2023
CytRx CEO Steven Kriegsman's 2021 pay jumps 592% to $7M
June 16, 2022
CytRx CEO Steven Kriegsman's 2020 pay falls 41% to $1M
June 14, 2021
CytRx CEO Steven Kriegsman's 2019 pay jumps 68% to $1.7M
June 12, 2020
CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
June 26, 2019